000 02774nam  2200421zi 4500
0019.932167
003CaOODSP
00520240109074414
006m     o  d f      
007cr mn|||||||||
008240108e202310  onc     ob   f000 0 eng d
020 |z9780660482231 |q(incorrect)
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-249/2023-1E-PDF|zHP40-249/2023E-PDF
24500|aReporting adverse events following immunization (AEFI) in Canada : |buser guide to completion and submission of the AEFI reports.
2463 |aUser guide : |bAEFI report form
250 |a[October 2023 edition].
264 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cOctober 2023.
264 4|c©2023
300 |a1 online resource (33 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Déclaration de manifestations cliniques inhabituelles (MCI) à la suite de l'immunisation au Canada : guide de l'utilisateur pour remplir et soumettre les rapports de déclaration de MCI.
500 |aCover title.
500 |a"PUB# 230350"--Verso of cover.
504 |aIncludes bibliographical references.
520 |a"This guide is intended to be used when completing the Report of AEFI for submission to P/T health authorities as well as to PHAC. Its purpose is to provide assistance on how to accurately complete the reporting form. It is not intended to guide treatment. Treatment of all AEFIs should proceed, as appropriate, prior to completing the AEFI form. Following the immediate care of the vaccine recipient, the AEFI form can be completed with all available information. Given the variation in practice between each of the provinces and territories, sections of the form may not be applicable to all settings. If in doubt, please contact your local public health unit"--Page 7.
650 0|aImmunization|xComplications|zCanada.
650 0|aVaccination|xComplications|zCanada.
650 0|aDrugs|xSide effects|xReporting|zCanada.
7102 |aPublic Health Agency of Canada, |eissuing body.
77508|tDéclaration de manifestations cliniques inhabituelles (MCI) à la suite de l'immunisation au Canada : |w(CaOODSP)9.932168
795 |tReporting adverse events following immunization (AEFI) in Canada : |b(April 2023)|w9.921366
85640|qPDF|s513 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP40-249-2023-1-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/reporting-adverse-events-following-immunization/user-guide-completion-submission-aefi-reports.html